Cytotoxic and genotoxic effects of acitretin, alone or in combination with psoralen-ultraviolet A or narrow-band ultraviolet B-therapy in psoriatic patients

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 753, Issue 1, 2013, Pages 42-47

  Silva, F S G ^a,b   Oliveira, H ^c   Moreiras, A ^d   Fernandes, J C ^d,e,f   Bronze da Rocha, E ^d,e   Figueiredo, A ^c   Custodio J B A ^a,b   Rocha Pereira, P ^e,g   Santos Silva, A ^d,e  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Acitretin; Genotoxicity; Narrowband ultraviolet B; Neotigason ; Psoralen ultraviolet A; Psoriasis therapy

Indexed keywords

ETRETIN; PSORALEN;

ADULT; APOPTOSIS; ARTICLE; CANCER RISK; CARCINOGENIC ACTIVITY; CELL PROLIFERATION; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; CYTOKINESIS; CYTOTOXICITY; DISEASE SEVERITY; DRUG SCREENING; FEMALE; GENOTOXICITY; HUMAN; LYMPHOCYTE CULTURE; MALE; MICRONUCLEUS TEST; NARROW BAND IMAGING; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PUVA; TREATMENT DURATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ACITRETIN; APOPTOSIS; CELL DIVISION; COMBINED MODALITY THERAPY; COMET ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; HUMANS; KERATOLYTIC AGENTS; LYMPHOCYTES; MALE; METHOXSALEN; MICRONUCLEUS TESTS; MIDDLE AGED; NECROSIS; PSORIASIS; PUVA THERAPY; RADIATION-SENSITIZING AGENTS; ULTRAVIOLET RAYS;

EID: 84876718354     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.12.017     Document Type: Article

References (51)

1. Murphy M., Kerr P., Grant-Kels J.M. The histopathologic spectrum of psoriasis. Clin. Dermatol. 2007, 25:524-528.
2. Schneider L.A., Hinrichs R., Scharffetter-Kochanek K. Phototherapy and photochemotherapy. Clin. Dermatol. 2008, 26:464-476.
3. Krueger G., Ellis C.N. Psoriasis-recent advances in understanding its pathogenesis and treatment. J. Am. Acad. Dermatol. 2005, 53:S94-S100.
4. Ghoreschi K., Weigert C., Rocken M. Immunopathogenesis and role of T cells in psoriasis. Clin. Dermatol. 2007, 25:574-580.
5. Dunn L.K., Gaar L.R., Yentzer B.A., O'Neill J.L., Feldman S.R. Acitretin in dermatology: a review. J. Drugs Dermatol. 2011, 10:772-782.
6. Ormerod A.D., Campalani E., Goodfield M.J.D. British association of dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br. J. Dermatol. 2010, 162:952-963.
7. Pastuszka M., Kaszuba A. Acitretin, a systemic retinoid for the treatment of psoriasis-current state of knowledge. Post Dermatol. Alergol. 2011, 4:285-292.
8. Lebwohl M. Acitretin in combination with UVB or PUVA. J. Am. Acad. Dermatol. 1999, 41:S22-S24.
9. Lebwohl M., Drake L., Menter A., Koo J., Gottlieb A.B., Zanolli M., Young M., McClelland P. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J. Am. Acad. Dermatol. 2001, 45:544-553.
10. Saurat J.H., Geiger J.M., Amblard P., Beani J.C., Boulanger A., Claudy A., Frenk E., Guilhou J.J., Grosshans E., Merot Y., et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988, 177:218-224.
11. Ozdemir M., Engin B., Baysal I., Mevlitoglu I. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis. Acta Derm. Venereol. 2008, 88:589-593.
12. Tanew A., Guggenbichler A., Honigsmann H., Geiger J.M., Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J. Am. Acad. Dermatol. 1991, 25:682-684.
13. Rajpara A.N., O'Neill J.L., Nolan B.V., Yentzer B.A., Feldman S.R. Review of home phototherapy. Dermatol. Online J. 2010, 16:2.
14. Tzung T.Y., Runger T.M. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem. Photobiol. 1998, 67:647-650.
15. Ferahbas A., Donmez-Altuntas H., Hamurcu Z., Aktas E., Utas S. Micronucleus evaluation in mitogen-stimulated lymphocytes of narrow-band (311nm TL01) UVB-treated patients. Photodermatol. Photoimmunol. Photomed. 2004, 20:81-85.
16. Hamurcu Z., Demirtas H., Ascioglu O., Donmez-Altuntas H., Aktas E. Micronucleus evaluation in mitogen-stimulated lymphocytes of PUVA treated patients. Tohoku J. Exp. Med. 2002, 198:11-21.
17. Baysal V., Sahin F., Erel A., Oruk S., Menevse S. The effect of PUVA treatment on sister chromatid exchange (SCE) values in psoriasis vulgaris patients. J. Dermatol. Treat 2003, 14:22-25.
18. Sardas S., Karahalil B., Karakaya A.E., Sasmaz R. Mutagenic risk in psoriatic patients before and after 8-methoxypsoralen and long-wave ultraviolet radiation. Mutat. Res. 1994, 312:79-83.
19. Alakhras R.S., Stephanou G., Demopoulos N.A., Nikolaropoulos S.S. Genotoxicity of all-trans retinoic acid (ATRA) and its steroidal analogue EA-4 in human lymphocytes and mouse cells in vitro. Cancer Lett. 2011, 306:15-26.
20. Georgala S., Papassotiriou I., Georgala C., Demetriou E., Schulpis K.H. Isotretinoin therapy induces DNA oxidative damage. Clin. Chem. Lab. Med. 2005, 43:1178-1182.
21. Trizna Z., Hsu T.C., Schantz S.P., Lee J.J., Hong W.K. Anticlastogenic effects of 13-cis-retinoic acid in vitro. Eur. J. Cancer 1992, 29AI:137-140.
22. Stephanou G., Andrianopoulos C., Tyrakis M., Konti M., Demopoulos N.A., Tsambaos D. In vitro antigenotoxic potential of acitretin in human lymphocytes treated with the antineoplastic alkylating agent ASE (NSC-71964). Toxicol. In Vitro 2004, 18:609-616.
23. Roche, Neotigason Information approved, Roche, 2008.
24. I.S.R. Guidelines, genotoxicity testing and data interpretation for pharmaceuticals intended for human use, 2008.
25. Vasquez M.Z. Combining the in vivo comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation. Mutagenesis 2010, 25:187-199.
26. Fredriksson T., Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978, 157:238-244.
27. Naldi L., Gambini D. The clinical spectrum of psoriasis. Clin. Dermatol. 2007, 25:510-518.
28. Fenech M. The in vitro micronucleus technique. Mutat. Res. 2000, 455:81-95.
29. I.C.f.S.i. Haematology, ICSH reference method for staining of blood and bone marrow films by azure B and eosin Y (Romanowsky stain). International Committee for Standardization in Haematology, Br. J. Haematol. 57 (1984) 707-710.
30. Surralles J., Xamena N., Creus A., Catalan J., Norppa H., Marcos R. Induction of micronuclei by five pyrethroid insecticides in whole-blood and isolated human lymphocyte cultures. Mutat. Res. 1995, 341:169-184.
31. OCDE, Test No. 487: In Vitro Mammalian Cell Micronucleus Test, OECD Publishing, 2010.
32. Fenech M., Crott J., Turner J., Brown S. Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay: description of the method and results for hydrogen peroxide. Mutagenesis 1999, 14:605-612.
33. Tice R.R., Andrews P.W., Hirai O., Singh N.P. The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. Adv. Exp. Med. Biol. 1991, 283:157-164.
34. Collins A.R., Oscoz A.A., Brunborg G., Gaivao I., Giovannelli L., Kruszewski M., Smith C.C., Stetina R. The comet assay: topical issues. Mutagenesis 2008, 23:143-151.
35. Karaman A., Aliagaoglu C., Pirim I. Sister chromatid exchange analysis in patients with psoriasis. Exp. Dermatol. 2008, 17:524-529.
36. Chen Y.J., Wu C.Y., Chen T.J., Shen J.L., Chu S.Y., Wang C.B., Chang Y.T. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J. Am. Acad. Dermatol. 2011, 65:84-91.
37. Ji J., Shu X., Sundquist K., Sundquist J., Hemminki K. Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br. J. Cancer 2009, 100:1499-1502.
38. Coimbra S., Oliveira H., Reis F., Belo L., Rocha S., Quintanilha A., Figueiredo A., Teixeira F., Castro E., Rocha-Pereira P., Santos-Silva A. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study. Am. J. Clin. Dermatol. 2010, 11:423-432.
39. S. Coimbra, A. Figueiredo, E. Castro, P. Rocha-Pereira, A. Santos-Silva, The roles of cells and cytokines in the pathogenesis of psoriasis, Int. J. Dermatol. 51 (2012) 389-395; quiz 395-388.
40. Alexandrescu D.T., Riordan N.H., Ichim T.E., Kauffman C.L., Kabigting F., Dutton C.T., Dasanu C.A. On the missing link between inflammation and cancer. Dermatol. Online J. 2011, 17:10.
41. Archier E., Devaux S., Castela E., Gallini A., Aubin F., Le Maitre M., Aractingi S., Bachelez H., Cribier B., Joly P., Jullien D., Misery L., Paul C., Ortonne J.P., Richard M.A. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J. Eur. Acad. Dermatol. Venereol. 2012, 26(Suppl. 3):22-31.
42. Wu J.H., Wilson J.B., Wolfreys A.M., Scott A., Jones N.J. Optimization of the comet assay for the sensitive detection of PUVA-induced DNA interstrand cross-links. Mutagenesis 2009, 24:173-181.
43. Coimbra S., Oliveira H., Reis F., Belo L., Rocha S., Quintanilha A., Figueiredo A., Teixeira F., Castro E., Rocha-Pereira P., Santos-Silva A. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J. Eur. Acad. Dermatol. Venereol. 2010, 24:1386-1394.
44. Johnson R., Staiano-Coico L., Austin L., Cardinale I., Nabeya-Tsukifuji R., Krueger J.G. PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes. Photochem. Photobiol. 1996, 63:566-571.
45. Szondy Z., Reichert U., Fesus L. Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ. 1998, 5:4-10.
46. Ozawa M., Ferenczi K., Kikuchi T., Cardinale I., Austin L.M., Coven T.R., Burack L.H., Krueger J.G. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J. Exp. Med. 1999, 189:711-718.
47. Bianchi B., Campolmi P., Mavilia L., Danesi A., Rossi R., Cappugi P. Monochromatic excimer light (308nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis. J. Eur. Acad. Dermatol. Venereol. 2003, 17:408-413.
48. Tuchinda C., Lim H.W., Strickland F.M., Guzman E.A., Wong H.K. Comparison of broadband UVB, narrowband UVB, broadband UVA and UVA1 on activation of apoptotic pathways in human peripheral blood mononuclear cells. Photodermatol. Photoimmunol. Photomed. 2007, 23:2-9.
49. Ballow M., Wang X., Xiang S., Allen C. Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells. J. Clin. Immunol. 2003, 23:46-54.
50. Dzhagalov I., Chambon P., He Y.W. Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J. Immunol. 2007, 178:2113-2121.
51. Ran L., Tan W., Tan S., Zhang R., Wang W., Zeng W. Effects of ATRA, acitretin and tazarotene on growth and apoptosis of Tca8113 cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2005, 25:393-396.